In vitro investigations have demonstrated that exogenous IL-37 inhibits lung cancer cell proliferation and migration (18), while suppressing epithelial-to-mesenchymal transition via the STAT3 signalling pathway. The gene discussed is IL37; the disease is lung carcinoma.